TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE Trademark
Trademark Overview
On Wednesday, March 7, 2018, a trademark application was filed for TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE with the United States Patent and Trademark Office. The USPTO has given the TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE trademark a serial number of 87824901. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2019. This trademark is owned by Ocular Science, Inc.. The TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE trademark is filed in the Pharmaceutical Products category with the following description:
Ophthalmic preparations
General Information
| Serial Number | 87824901 |
| Word Mark | TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE |
| Filing Date | Wednesday, March 7, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, April 8, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 10, 2018 |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2%" AND "BY OCULAR SCIENCE" |
| Description of Mark | The mark consists of the words "Timolol / Brimonidine Tartrate / Dorzolamide Ophthalmic Solution 0.5% / 0.2% / 2%" above the words of "OMNI by OCULAR SCIENCE". The "Timolol / Brimonidine Tartrate /" words are above the "Dorzolamide Ophthalmic Solution" words. The "Dorzolamide Ophthalmic Solution" words are above the "0.5% / 0.2% / 2%" words. The "Timolol / Brimonidine Tartrate / Dorzolamide Ophthalmic Solution 0.5% / 0.2% / 2%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI". |
| Goods and Services | Ophthalmic preparations |
| Pseudo Mark | TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION ZERO POINT FIVE PERCENT / ZERO POINT TWO PERCENT / TWO PERCENT OMNI BY OCULAR SCIENCE |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 14, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ocular Science, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90266 |
| Party Name | Ocular Science, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90266 |
Trademark Events
| Event Date | Event Description |
| Monday, April 8, 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, April 8, 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, September 4, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 10, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 10, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 20, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, June 2, 2018 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, May 31, 2018 | ASSIGNED TO LIE |
| Wednesday, May 16, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 16, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 16, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 16, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 16, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 10, 2018 | ASSIGNED TO EXAMINER |
| Thursday, March 15, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 14, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, March 10, 2018 | NEW APPLICATION ENTERED IN TRAM |
